October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

GAP Pipeline Brief: Cornell University Awards Nearly $293,000 Through Ignite Innovation Acceleration to Advance Six Commercialization Projects

Get our Weekly GAP Insights

Join Us

October 16-17, 2025 / Seattle, WA

The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

The Story

Award & Investment Overview

Cornell University has awarded $292,869 to six research teams through the spring 2026 cycle of its Ignite Innovation Acceleration program. Managed by Cornell’s Center for Technology Licensing (CTL), the program provides milestone-driven GAP funding to advance university technologies toward licensing, startup formation, and industry partnerships.

Each project received a grant of up to $50,000 to address specific technical or commercial development milestones. The funded technologies span gene therapy, cancer immunotherapy, infrared imaging, poultry health, carbon capture, and sustainable landscaping.

The awards support research teams across four Cornell colleges. Two teams are evaluating new venture opportunities, while another is testing its technology with a commercial partner. The portfolio demonstrates how targeted, non-dilutive funding can help university innovations progress toward market readiness.

Approach & Ecosystem Context

Ignite Innovation Acceleration is part of Cornell’s broader Ignite funding series, administered by the Center for Technology Licensing. The program helps researchers address development gaps that can prevent promising technologies from attracting commercial partners, securing licenses, or forming viable startups.

Funding is tied to specific milestones, including proof-of-concept validation, prototype development, market research, and regulatory preparation. Projects are evaluated for their potential to advance toward licensing, venture formation, or industry collaboration.

Cornell reports that more than 44% of previously funded Ignite Innovation Acceleration projects have progressed to a licensing agreement or startup formation. This provides a useful measure of commercialization activity beyond the initial funding award.

From a Mind the GAP perspective, Cornell’s approach illustrates the value of connecting relatively modest funding awards to clearly defined commercialization outcomes. Rather than treating all technologies as startup candidates, the program supports multiple routes to market based on the development needs and commercial opportunities of each project.

Ignite Innovation Acceleration also operates alongside Cornell’s Fellow for New Ventures and Startup Projects programs, providing additional venture development resources within the university’s commercialization ecosystem.

Innovation & Technology

1. Compact, Programmable Gene-Insertion Tool for Precision Gene Therapy

Lead Researcher: Joseph Peters

Professor Joseph Peters’ laboratory has developed a compact programmable transposon system inspired by CRISPR-associated transposons. The technology enables guide-RNA-directed insertion of DNA sequences in bacteria and is designed to address the difficulty of inserting larger genetic sequences using conventional gene-editing tools. Further development could support gene therapies that address multiple disease-causing mutations within a single gene, although therapeutic delivery and effectiveness remain to be demonstrated.

2. Precision-Engineered Cancer Vaccines Targeting Tumor Sugar Molecules

Lead Researcher: Matthew DeLisa | Startup: Gauntlet Bio

Matthew DeLisa’s research group has developed a vaccine platform that positions carbohydrate targets at defined locations on carrier proteins to improve immune responses. The approach builds on proof-of-concept studies involving bacterial carbohydrates that demonstrated improved protection in mice. The team is extending the technology to tumor-associated carbohydrates, with potential applications in cancer immunotherapy. An early-stage company, Gauntlet Bio, has been formed to commercialize the platform.

3. Ultra-Thin Optical Lens Technology for Compact Cameras

Lead Researcher: Nicholas Behrens

Nicholas Behrens is advancing a flat optical technology known as pancake meta-optics, originating from research led by Professor Francesco Monticone. The technology reduces the physical depth of imaging systems while seeking to preserve imaging performance. Initial commercialization efforts focus on compact infrared cameras for drones and defense applications, with additional potential in thermal imaging, night-vision devices, and augmented reality systems. The project is progressing toward prototype development.

4. Virus-Delivered Treatment to Stop Salmonella in Chickens

Lead Researcher: Erick Maosa

Erick Maosa and colleagues are developing a bacteriophage-based treatment designed to reduce Salmonella colonization in poultry. The technology uses a virus that specifically infects Salmonella to deliver instructions for producing a fatty acid that interferes with the bacterium’s ability to invade the gut. The proposed treatment could be administered through drinking water to newly hatched chicks, offering a potential alternative to conventional antimicrobial approaches for poultry producers.

5. Light-Powered Carbon Capture Using Sunlight

Lead Researcher: Phillip Milner

Professor Phillip Milner’s laboratory has developed a carbon capture approach that uses different wavelengths of light to capture and release carbon dioxide. The technology aims to reduce the heating and pressurization requirements associated with conventional carbon capture systems. By potentially operating with sunlight, the approach could support lower-energy carbon capture applications in industrial facilities, biogas operations, and direct air capture systems.

6. Native Lawn: A Low-Maintenance Alternative to Traditional Grass

Lead Researcher: Todd Bittner | Commercial Partner: Meadow Lab

Cornell Botanic Gardens has developed a native plant seed mixture designed to replace conventional turf grass with a lower-maintenance alternative. Long-term research found that the lawn maintained more than 85% native plant coverage after 15 years while supporting greater insect biodiversity and reducing irrigation, mowing, and chemical inputs. Cornell is testing the technology with commercial partner Meadow Lab, with potential licensing opportunities involving nurseries, landscaping companies, and sod producers.

Potential Market Uses and Applications

Potential Clinical and Therapeutic Applications

  • Precision gene therapy and programmable DNA insertion.
  • Cancer vaccines targeting tumor-associated carbohydrates.
  • Pharmaceutical licensing and therapeutic platform development.

Potential Industrial and Imaging Applications

  • Compact infrared cameras for drones and surveillance.
  • Thermal imaging, night-vision devices, and lightweight optical systems.
  • Defense, security, and specialized imaging equipment.

Potential Agriculture and Food Safety Applications

  • Salmonella prevention in commercial poultry operations.
  • Bacteriophage-based livestock health technologies.
  • Poultry food safety and contamination reduction.

Potential Energy and Environmental Applications

  • Light-powered carbon capture for industrial facilities.
  • Direct air capture and biogas processing.
  • Lower-energy carbon dioxide separation technologies.

Potential Landscaping and Sustainability Applications

  • Native lawn seed products and commercial landscaping.
  • Low-maintenance residential and institutional lawns.
  • Seed licensing, sod production, and biodiversity-focused landscaping.

Related Topics

Cornell University, Center for Technology Licensing, Ignite Innovation Acceleration, Ignite GAP Funding, university commercialization, proof-of-concept funding, translational research, technology transfer, university startups, Gauntlet Bio, gene therapy, cancer vaccines, meta-optics, infrared imaging, Salmonella control, bacteriophage technology, carbon capture, native lawns, sustainable landscaping, Meadow Lab, commercialization grants, licensing, venture formation, industry partnerships

About innovosource

innovosource tracks GAP programs, including proof-of-concept programs, startup accelerators, translational research initiatives, university venture funds, and commercialization ecosystems that help move university innovations from research to market.

Our coverage is informed by the Mind the GAP Initiative and the GAP COA consortium activity, providing practical insights into the evolving commercialization landscape.

Learn more:

Source

https://news.cornell.edu/stories/2026/10/cornell-technologies-receive-ignite-innovation-funding-path-commercialization

Consortium For Gap Fund and Accelerator ProgramS

The Consortium provides a dedicated, institutional coordinating forum for collective insight, program refinement, and structured engagement with aligned commercial, investment, and philanthropic partners.

GAP are an interdependent institutional innovation and capital strategy that includes:

  • Translational research

  • Proof of concept programs

  • Startup accelerators

  • University venture funds

Get GAP Insights